Publicaciones (44) Publicaciones de Jesus Carlos Fernandez López

2024

  1. Effectiveness Of Tocilizumab In Aortitis And Aneurysms Associated With Giant Cell Arteritis

    European Journal of Internal Medicine, Vol. 129, pp. 78-86

  2. Higher Synovial Immunohistochemistry Reactivity of IL-17A, Dkk1, and TGF-β1 in Patients with Early Psoriatic Arthritis and Rheumatoid Arthritis Could Predict the Use of Biologics

    Biomedicines, Vol. 12, Núm. 4

2023

  1. Increased synovial immunohistochemistry reactivity of TGF-β1 in erosive peripheral psoriatic arthritis

    BMC musculoskeletal disorders, Vol. 24, Núm. 1, pp. 246

  2. Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients

    Clinical and experimental rheumatology, Vol. 41, Núm. 4, pp. 829-836

2022

  1. PROCOAC (PROspective COhort of A Coruña) description: Spanish prospective cohort to study osteoarthritis

    Reumatologia Clinica, Vol. 18, Núm. 2, pp. 100-104

  2. Tocilizumab in visual involvement of giant cell arteritis: a multicenter study of 471 patients

    Therapeutic Advances in Musculoskeletal Disease, Vol. 14

2021

  1. Tocilizumab in refractory Caucasian Takayasu’s arteritis: a multicenter study of 54 patients and literature review

    Therapeutic Advances in Musculoskeletal Disease, Vol. 13

2020

  1. Abatacept in interstitial lung disease associated with rheumatoid arthritis: national multicenter study of 263 patients

    Rheumatology (Oxford, England), Vol. 59, Núm. 12, pp. 3906-3916

  2. Association of serum anti-centromere protein F antibodies with clinical response to infliximab in patients with rheumatoid arthritis: A prospective study

    Seminars in Arthritis and Rheumatism, Vol. 50, Núm. 5, pp. 1101-1108

  3. Impact of Comorbidity on Physical Function in Patients With Ankylosing Spondylitis and Psoriatic Arthritis Attending Rheumatology Clinics: Results From a Cross-Sectional Study

    Arthritis Care and Research, Vol. 72, Núm. 6, pp. 822-828

  4. Tocilizumab in giant cell arteritis: differences between the GiACTA trial and a multicentre series of patients from the clinical practice

    Clinical and experimental rheumatology, Vol. 38, Núm. 2, pp. 112-119

2019

  1. Objectives and methodology of BIOBADASER phase III

    Reumatologia Clinica, Vol. 15, Núm. 4, pp. 229-236

  2. Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice

    Seminars in Arthritis and Rheumatism, Vol. 49, Núm. 1, pp. 126-135

2017

  1. A replication study and meta-analysis of mitochondrial DNA variants in the radiographic progression of knee osteoarthritis

    Rheumatology (United Kingdom), Vol. 56, Núm. 2, pp. 263-270

  2. Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project

    Journal of Clinical Lipidology, Vol. 11, Núm. 3, pp. 749-756.e3

  3. Mitochondrial DNA haplogroups influence the risk of incident knee osteoarthritis in OAI and CHECK cohorts. A meta-Analysis and functional study

    Annals of the Rheumatic Diseases, Vol. 76, Núm. 6, pp. 1114-1122

  4. Prevalencia de patología podológica, funcionalidad y dolor del pie en personas con artritis reumatoide y psoriásica

    XXI Encuentro Internacional de Investigación en Cuidados

2015

  1. Body mass index and doses at organs at risk in a mediterranean population treated with postoperative vaginal cuff brachytherapy

    Cancer Research and Treatment, Vol. 47, Núm. 3, pp. 473-479

  2. Dosimetric analysis of rectal filling on rectal doses during vaginal cuff brachytherapy

    Brachytherapy, Vol. 14, Núm. 4, pp. 458-463

  3. Mitochondrial DNA haplogroups modulate the radiographic progression of Spanish patients with osteoarthritis

    Rheumatology International, Vol. 35, Núm. 2, pp. 337-344